Doc Guide -- A study comparing the efficacy and safety of tacrolimus and everolimus in combination with everolimus and cyclosporine A (CsA) in heart transplant recipients with chronic renal failure, has demonstrated safety and efficacy for both treatment combinations, researchers said here August 19 at the 23rd International Congress of the Transplant Society (ICTS).
